These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Health supervision for children with neurofibromatosis. Hersh JH; Pediatrics; 2008 Mar; 121(3):633-42. PubMed ID: 18310216 [TBL] [Abstract][Full Text] [Related]
24. Schematic representation of NF-1 clinical features in Spanish. Willson PC; Coronado T Neurofibromatosis; 1989; 2(2):125-6. PubMed ID: 2516456 [No Abstract] [Full Text] [Related]
25. Diffusion of information about neurofibromatosis type 1 DNA testing. Hofman KJ Am J Med Genet; 1994 Feb; 49(3):299-301. PubMed ID: 8209889 [TBL] [Abstract][Full Text] [Related]
26. An unusual association of a rare variant of Friedreich's ataxia with type-I neurofibromatosis in a Nigerian Fulani family: a 5-year follow-up study. Ahmed H; Falope ZF West Afr J Med; 1999; 18(2):133-8. PubMed ID: 10504872 [TBL] [Abstract][Full Text] [Related]
27. Neurofibromatosis types 1 and 2. Yohay K Neurologist; 2006 Mar; 12(2):86-93. PubMed ID: 16534445 [TBL] [Abstract][Full Text] [Related]
28. [Neurofibromatosis I: a clinical series and genetic correlations]. Colli R; Radaelli S; Bianchi GA Minerva Pediatr; 1997 Apr; 49(4):155-61. PubMed ID: 9244842 [TBL] [Abstract][Full Text] [Related]
32. [Recommendations for the treatment of neurofibromatosis type 1]. Pinson S; Créange A; Barbarot S; Stalder JF; Chaix Y; Rodriguez D; Sanson M; Bernheim A; D'incan M; Doz F; Stoll Cl; Combemale P; Kalifa C; Zeller J; Teillac-Hamel D; Lyonnet S; Zerah M; Lacour JP; Guillot B; Wolkenstein P; J Fr Ophtalmol; 2002 Apr; 25(4):423-33. PubMed ID: 12011750 [No Abstract] [Full Text] [Related]
33. Management of the child with neurofibromatosis Type I, von Recklinghausen Disease. Cheifetz A Penn Dent J (Phila); 2001; 101():5, 8, 32. PubMed ID: 15484633 [No Abstract] [Full Text] [Related]
34. [Neurofibromatosis: clinical and genetic study (author's transl)]. Carnevale A; del Castillo V; Ruíz-Maldonado R; Tamayo L Rev Invest Clin; 1980; 31(4):363-8. PubMed ID: 6768120 [No Abstract] [Full Text] [Related]
35. Clinical presentation of patients with neurofibromatosis type 1 in infancy and childhood: genetic traits and gender effects. Suenobu S; Akiyoshi K; Maeda T; Korematsu S; Izumi T J Child Neurol; 2008 Nov; 23(11):1282-7. PubMed ID: 18984837 [TBL] [Abstract][Full Text] [Related]
36. From the clinic to the research laboratory. The role of the clinician in molecular genetic studies. Palmer SE; Stephens K Arch Dermatol; 1993 Nov; 129(11):1424-9. PubMed ID: 8239701 [TBL] [Abstract][Full Text] [Related]
37. Genetic and clinical considerations in six cases with neurofibromatosis type 1. Buteică E; Stoicescu I; Burada F; Stănoiu B Rom J Morphol Embryol; 2007; 48(3):243-8. PubMed ID: 17914490 [TBL] [Abstract][Full Text] [Related]
38. A geneticist's view of neurofibromatosis. Knudson AG Adv Neurol; 1981; 29():237-43. PubMed ID: 6798839 [No Abstract] [Full Text] [Related]
39. Tumor LOH analysis provides reliable linkage information for prenatal genetic testing of sporadic NF1 patients. Serra E; Pros E; García C; López E; Gili ML; Gómez C; Ravella A; Capellá G; Blanco I; Lázaro C Genes Chromosomes Cancer; 2007 Sep; 46(9):820-7. PubMed ID: 17563086 [TBL] [Abstract][Full Text] [Related]